Torsten Steinbrunn

770 total citations
21 papers, 460 citations indexed

About

Torsten Steinbrunn is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Torsten Steinbrunn has authored 21 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 14 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Torsten Steinbrunn's work include Multiple Myeloma Research and Treatments (16 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Protein Degradation and Inhibitors (5 papers). Torsten Steinbrunn is often cited by papers focused on Multiple Myeloma Research and Treatments (16 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Protein Degradation and Inhibitors (5 papers). Torsten Steinbrunn collaborates with scholars based in Germany, United States and Spain. Torsten Steinbrunn's co-authors include Manik Chatterjee, Thorsten Stühmer, Ralf C. Bargou, Hermann Einsele, Andreas Rosenwald, Claudia Hofmann, S. Kressmann, Elisabeth Müller, Mindaugas Andrulis and Tracey Heimberger and has published in prestigious journals such as Blood, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Torsten Steinbrunn

21 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torsten Steinbrunn Germany 11 348 211 98 57 56 21 460
D Chauhan United States 5 274 0.8× 192 0.9× 151 1.5× 26 0.5× 81 1.4× 7 403
Divyamani Srinivasan United States 6 252 0.7× 169 0.8× 109 1.1× 39 0.7× 22 0.4× 7 390
YT Tai United States 6 366 1.1× 245 1.2× 247 2.5× 25 0.4× 90 1.6× 10 543
Barbara Szymanska Australia 6 306 0.9× 125 0.6× 140 1.4× 16 0.3× 75 1.3× 7 499
Rosemary A Fryer United Kingdom 5 225 0.6× 140 0.7× 145 1.5× 21 0.4× 35 0.6× 8 360
Turner Kufe United States 6 216 0.6× 128 0.6× 164 1.7× 24 0.4× 148 2.6× 7 368
Pravina Fernandez United States 4 514 1.5× 103 0.5× 79 0.8× 29 0.5× 52 0.9× 11 572
Andrew Volk United States 11 387 1.1× 165 0.8× 58 0.6× 23 0.4× 114 2.0× 25 547
Kaat Durinck Belgium 13 335 1.0× 98 0.5× 93 0.9× 26 0.5× 101 1.8× 26 548
Agnieszka A. Wendorff United States 6 446 1.3× 179 0.8× 99 1.0× 24 0.4× 100 1.8× 8 642

Countries citing papers authored by Torsten Steinbrunn

Since Specialization
Citations

This map shows the geographic impact of Torsten Steinbrunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Steinbrunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Steinbrunn more than expected).

Fields of papers citing papers by Torsten Steinbrunn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Steinbrunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Steinbrunn. The network helps show where Torsten Steinbrunn may publish in the future.

Co-authorship network of co-authors of Torsten Steinbrunn

This figure shows the co-authorship network connecting the top 25 collaborators of Torsten Steinbrunn. A scholar is included among the top collaborators of Torsten Steinbrunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torsten Steinbrunn. Torsten Steinbrunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stühmer, Thorsten, Martin Schreder, Torsten Steinbrunn, et al.. (2024). Association of ADAM family members with proliferation signaling and disease progression in multiple myeloma. Blood Cancer Journal. 14(1). 156–156. 2 indexed citations
2.
Hopff, Sina M., Annika Y. Claßen, Gesine Bug, et al.. (2024). Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational study. Journal of Infection. 89(2). 106220–106220. 7 indexed citations
3.
Schwarzfischer, Marlene, Hilka Rauert‐Wunderlich, Torsten Steinbrunn, et al.. (2024). Functional Investigation of IGF1R Mutations in Multiple Myeloma. Cancers. 16(11). 2139–2139. 2 indexed citations
4.
Solimando, Antonio Giovanni, Matteo Da Vià, Niccolò Bolli, & Torsten Steinbrunn. (2022). The Route of the Malignant Plasma Cell in Its Survival Niche: Exploring “Multiple Myelomas”. Cancers. 14(13). 3271–3271. 4 indexed citations
5.
Kraus, Sabrina, Alexander Dierks, Leo Rasche, et al.. (2021). 68Ga-Pentixafor PET/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative Neoplasms. Journal of Nuclear Medicine. 63(1). 96–99. 20 indexed citations
6.
Weißbach, Susann, Jochen Bodem, Christian Langer, et al.. (2020). Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines. Cancers. 12(2). 455–455. 10 indexed citations
7.
Stühmer, Thorsten, Anja Mottok, Claus Jürgen Scholz, et al.. (2019). RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS. Haematologica. 105(9). 2316–2326. 13 indexed citations
8.
Nerreter, Thomas, Sebastian Letschert, Sophia Danhof, et al.. (2019). Super-resolution microscopy reveals ultra-low expression of CD19 on myeloma cells that triggers elimination by CAR-T cells. Clinical Lymphoma Myeloma & Leukemia. 19(10). e166–e166. 2 indexed citations
9.
Haertle, Larissa, Max Bittrich, Ramya Potabattula, et al.. (2018). Focusing PI and IMiD Resistance in Multiple Myeloma: Impact of DNA Methylation. Blood. 132(Supplement 1). 404–404. 1 indexed citations
10.
Rasche, Leo, Emmanuelle Ménoret, Valentina Dubljevic, et al.. (2016). A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement. Clinical Cancer Research. 22(17). 4341–4349. 47 indexed citations
11.
Müller, Elisabeth, Sebastian Bauer, Thorsten Stühmer, et al.. (2016). Pan-Raf co-operates with PI3K-dependent signalling and critically contributes to myeloma cell survival independently of mutated RAS. Leukemia. 31(4). 922–933. 16 indexed citations
12.
Langer, Christian, Stefan Knop, Jordan Pischimarov, et al.. (2016). Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma. Oncotarget. 7(25). 38762–38774. 3 indexed citations
13.
Steinbrunn, Torsten, Manik Chatterjee, Ralf C. Bargou, & Thorsten Stühmer. (2014). Efficient Transient Transfection of Human Multiple Myeloma Cells by Electroporation – An Appraisal. PLoS ONE. 9(6). e97443–e97443. 18 indexed citations
14.
Hofmann, Claudia, Thorsten Stühmer, Reinhard Wetzker, et al.. (2014). PI3K‐dependent multiple myeloma cell survival is mediated by the PIK3CA isoform. British Journal of Haematology. 166(4). 529–539. 16 indexed citations
15.
Leich, Ellen, Susann Weißbach, Hans‐Ulrich Klein, et al.. (2013). Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules. Blood Cancer Journal. 3(2). e102–e102. 43 indexed citations
16.
Steinbrunn, Torsten, Daniela Siegmund, Mindaugas Andrulis, et al.. (2012). Integrin-linked kinase is dispensable for multiple myeloma cell survival. Leukemia Research. 36(9). 1165–1171. 10 indexed citations
17.
Chatterjee, Manik, Mindaugas Andrulis, Thorsten Stühmer, et al.. (2012). The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma. Haematologica. 98(7). 1132–1141. 132 indexed citations
18.
Steinbrunn, Torsten, Thorsten Stühmer, Cyrus Sayehli, et al.. (2012). Combined targeting of MEK/MAPK and PI3K/Akt signalling in multiple myeloma. British Journal of Haematology. 159(4). 430–440. 43 indexed citations
19.
Steinbrunn, Torsten, Thorsten Stühmer, Stefan Gattenlöhner, et al.. (2010). Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival. Blood. 117(6). 1998–2004. 69 indexed citations
20.
Steinbrunn, Torsten, Thorsten Stühmer, Manik Chatterjee, Stefan Gattenlöhner, & Ralf C. Bargou. (2009). Analysis of PKB/Akt-Signaling and Oncogenic Ras in Multiple Myeloma.. Blood. 114(22). 831–831. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Chauhan Breakdown of academic impact, for papers by Divyamani Srinivasan Breakdown of academic impact, for papers by YT Tai Breakdown of academic impact, for papers by Barbara Szymanska Breakdown of academic impact, for papers by Rosemary A Fryer Breakdown of academic impact, for papers by Turner Kufe Breakdown of academic impact, for papers by Pravina Fernandez Breakdown of academic impact, for papers by Andrew Volk Breakdown of academic impact, for papers by Kaat Durinck Breakdown of academic impact, for papers by Agnieszka A. Wendorff
Rankless by CCL
2026